Rockefeller Capital Management L.P. Buys 14,032 Shares of Colgate-Palmolive (NYSE:CL)

Rockefeller Capital Management L.P. lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 0.7% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 2,165,600 shares of the company’s stock after buying an additional 14,032 shares during the quarter. Colgate-Palmolive comprises about 0.6% of Rockefeller Capital Management L.P.’s portfolio, making the stock its 22nd largest holding. Rockefeller Capital Management L.P.’s holdings in Colgate-Palmolive were worth $224,806,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. E Fund Management Hong Kong Co. Ltd. acquired a new stake in Colgate-Palmolive during the second quarter worth approximately $25,000. Continuum Advisory LLC boosted its stake in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after purchasing an additional 125 shares during the period. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive during the 3rd quarter worth $53,000. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter worth $64,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.2 %

Shares of CL stock opened at $96.76 on Friday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of $79.05 billion, a P/E ratio of 27.73, a P/E/G ratio of 3.45 and a beta of 0.42. Colgate-Palmolive has a twelve month low of $75.50 and a twelve month high of $109.30. The stock’s fifty day simple moving average is $97.51 and its 200 day simple moving average is $98.57.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. TD Cowen lowered their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research report on Monday, October 28th. Piper Sandler initiated coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price objective for the company. Finally, UBS Group upped their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus target price of $105.11.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.34% of the stock is owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.